Select Page
Applications » ROXY Reactors » Disulfide bond reduction

Disulfide bond reduction

ROXY Reactors for disulfide bond reduction

The ROXY Exceed with an EC Reactor has been developed for fast and efficient reduction of disulfide bonds in proteins. The reduction of intra- and intermolecular disulfide bonds is a small but crucial step in the workflow for successful structure elucidation and assignment of the bonding sites by MS. The method is based on an electric potential to trigger the reduction reaction, no reductive chemicals are used.

Traditionally, reduction is performed using concentrated chemicals, e.g. dithiothreitol (DTT) that needs to be removed prior LC/MS analysis. Alternatively, thiol – free reducing agents such as TCEP (tris (2-carboxyethyl) phosphine) can be used. However, sample preparation remains laborious and difficult to combine with on-line LC/MS. Electrochemistry in an on-line setup with MS is clean, no chemicals are needed and the result can be monitored instantaneously.

For more details: see our technology page.

Breaking of a disulfide bond in an electrochemical flow-through reactor requires a potential of about -1 V.

Insulin

Insulin, a small protein of 5733 Da is used as model compound for the S-S reduction. It consists of 51 amino acids forming two chains, A and B, and contains 3 disulfide bonds. Two interchain S-S bonds connecting chain A and B and one intrachain S-S bond located on chain A. The disulfide bonds can be completely reduced using an electrochemical reactor.

Almost complete reduction of all three S-S bonds in Insulin was obtained using the ROXY EC system up-front MS.

Application notes

 

Name
Doc#
Size
Download
Superior Characterization of Protein Therapeutics
210_003_01
1.12 MB
Reduction of Disulfide Bonds in Proteins
210_006_05
0.83 MB
Reduction and Engineering of mAbs
210_008_04
0.69 MB
Electrochemical Reduction of Biopharmaceuticals in HDX-MS
210_009_06
2.43 MB
Monitoring Electrochemical Reduction
210_010_04
1.00 MB
Superior Reduction of Disulfide Bonds in HDXMS
210_013_02
1.37 MB
Metabolism of 3 New Cardiovascular Drugs
210_014_02
1.20 MB
Electrochemical Reduction of Biopharmaceuticals
210_015_02
0.81 MB
Antibody subunit analysis via EC Reduction
210_000_01
0.67 MB
Improved and universal inline electrochemical reduction of mAbs
210_000_02
2.05 MB

Posters

 

Name
Doc#
Size
Download
Reduction (Insuline, Avastin Fab)
221_241_01
1.67 MB
New EC cell for reduction of protein disulfide bonds in HDX─MS (Insuline, NGF, VEGF)
221_244_01
5.42 MB
EC Reduction of Disulfide Bonds in Proteins & Biopharmaceuticals (Insulin, Avastin Fab, NGF, VEGF)
221_248_02
4.88 MB